Science first

We subscribe to the philosophy of multiplex testing: with only one blood sample, multiplex tests can simultaneously detect IgE to multiple allergen extracts/molecular allergens in a single assay run. Multiplex tests provide the most complete picture of a patient's sensitisation profile possible, whereas a singleplex test may leave gaps and empty spaces that render the picture incomplete.
The ALEX³ allergen panel is comprised of 82 allergen extracts and 218 molecular allergens - which makes it the largest panel of molecular allergens on the market to date. MADx uses allergen extracts where molecular allergens are not yet well-characterised or redundant due to a high degree of cross-reactivity. Molecular allergens are used where allergen extracts are described as unstable. The combination of both ensures the accurate profiling of a patient's sensitisation status.
An extensive academic collaboration network ensures the translation of the newest findings in basic research into our products. This mutually benefical exchange with the scientific communities from the Americas, Asia, Australia, and Europe resulted in a plethora of molecular allergens unique to the ALEX³ platform and the inclusion of a cross-reactive carbohydrate inhibitor in the standard ALEX³ test kits. Both features allow for a thorough and highly specific IgE profiling for a diverse range of allergic patients. This leads to a quicker route to fitting therapeutic options.